SPIA
EDIT icon

Steward Partners Investment Advisory’s Editas Medicine EDIT Stock Holding History

Steward Partners Investment Advisory’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.69K Buy
829
+102
+14% +$298 ﹤0.01% 4163
2026
Q1 		$1.8K Hold
727
– – ﹤0.01% 4086
2025
Q4 		$1.49K Sell
727
-2
-0.3% -$6 ﹤0.01% 4019
2025
Q3 		$2.53K Buy
729
+204
+39% +$569 ﹤0.01% 3860
2025
Q2 		$1.16K Hold
525
– – ﹤0.01% 3835
2025
Q1 		$609 Hold
525
– – ﹤0.01% 3837
2024
Q4 		$667 Buy
525
+100
+24% +$255 ﹤0.01% 3815
2024
Q3 		$1.45K Sell
425
-320
-43% -$1.39K ﹤0.01% 3493
2024
Q2 		$3.48K Buy
745
+63
+9% +$355 ﹤0.01% 3151
2024
Q1 		$5.06K Buy
682
+87
+15% +$723 ﹤0.01% 3041
2023
Q4 		$6.03K Sell
595
-47
-7% -$413 ﹤0.01% 2894
2023
Q3 		$5.01K Sell
642
-195
-23% -$1.67K ﹤0.01% 2828
2023
Q2 		$6.89K Sell
837
-610
-42% -$5.31K ﹤0.01% 2687
2023
Q1 		$10.5K Buy
1,447
+502
+53% +$4.46K ﹤0.01% 2518
2022
Q4 		$8.38K Buy
945
+80
+9% +$878 ﹤0.01% 2596
2022
Q3 		$11K Buy
865
+75
+9% +$1.17K ﹤0.01% 2481
2022
Q2 		$9K Sell
790
-501
-39% -$6.71K ﹤0.01% 2544
2022
Q1 		$25K Sell
1,291
-217
-14% -$4.03K ﹤0.01% 2258
2021
Q4 		$40K Sell
1,508
-2,690
-64% -$92.6K ﹤0.01% 2012
2021
Q3 		$172K Buy
4,198
+2,019
+93% +$111K ﹤0.01% 1323
2021
Q2 		$123K Sell
2,179
-450
-17% -$16.6K ﹤0.01% 1969
2021
Q1 		$110K Buy
2,629
+1,917
+269% +$109K ﹤0.01% 1565
2020
Q4 		$50K Buy
712
+580
+439% +$23.8K ﹤0.01% 1669
2020
Q3 		$4K Buy
132
+85
+181% +$2.77K ﹤0.01% 2419
2020
Q2 		$1K Buy
+47
New +$1.23K ﹤0.01% 2558
2020
Q1 		– Sell
-800
Closed -$23K – 2538
2019
Q4 		$23K Sell
800
-800
-50% -$20K ﹤0.01% 1725
2019
Q3 		$36K Buy
1,600
+500
+45% +$12.4K ﹤0.01% 1491
2019
Q2 		$27K Buy
+1,100
New +$26.3K ﹤0.01% 1582
2018
Q4 		– Sell
-1,150
Closed -$37K – 1121
2018
Q3 		$37K Buy
1,150
+450
+64% +$14.5K ﹤0.01% 1311
2018
Q2 		$25K Buy
700
+150
+27% +$5.31K ﹤0.01% 1372
2018
Q1 		$18K Sell
550
-25
-4% -$891 ﹤0.01% 1366
2017
Q4 		$17K Buy
575
+375
+188% +$9.44K ﹤0.01% 1178
2017
Q3 		$4K Hold
200
– – ﹤0.01% 1345
2017
Q2 		$3K Hold
200
– – ﹤0.01% 1332
2017
Q1 		$4K Hold
200
– – ﹤0.01% 1168
2016
Q4 		$3K Buy
+200
New +$3.04K ﹤0.01% 712

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Steward Partners Investment Advisory's EDIT Position: Q2 2026 in Review

Steward Partners Investment Advisory increased its Editas Medicine (EDIT) stake by 14% in Q2 2026, buying an estimated $298 and bringing the position to 829 shares worth $2.69K. The position accounts for ﹤0.01% of the portfolio, ranked #4163.

Steward Partners Investment Advisory first reported a position in EDIT in Q4 2016 and has held it in 36 quarters since. The position peaked at $172K in Q3 2021. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Steward Partners Investment Advisory held 829 shares of Editas Medicine worth $2.69K as of Q2 2026.
  • Steward Partners Investment Advisory bought 102 Editas Medicine shares in Q2 2026, an estimated $298.
  • Editas Medicine made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #4163 holding.
  • Steward Partners Investment Advisory first reported a position in Editas Medicine in Q4 2016 and has held it in 36 quarters since.
  • Steward Partners Investment Advisory's Editas Medicine position peaked at $172K in Q3 2021.
  • 214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.